MCLEAN, Va., Aug. 12, 2011 (GLOBE NEWSWIRE) -- Exmovere Holdings, Inc., a biomedical engineering company listed on the Frankfurt Stock Exchange under the symbol (X3M.F), today announced signing a definitive agreement with ZEONS Global to secure sales and distribution support around the world. The agreement secures agency-level support for all facets of customer contact and development, sales and distribution support, as well as channel-based marketing for Exmovere products. As a starting point in the relationship, ZEONS plans to market and sell evaluation kits for Exmobaby infant pajamas in Latin America, the Middle East, North Africa and South Asia. ZEONS will initially focus on contacting and recruiting potential medical professionals, hospitals, care facilities and companies in the international medical and healthcare field.
Exmobaby evaluation kits are not available for sale directly to the general public at this time, but only to interested pediatricians, hospitals, clinics, day care centers and other professional users. The purpose of the kits is to provide a complete Exmobaby product – a washable, conductive fabric-based biosensor pajama for infants – for implementation, research and evaluation by physicians and professional care providers prior to releasing the product to consumers. Additional information on Exmobaby and the evaluation kit order page can be found on the company's website at http://exmobaby.exmovere.com.
With their worldwide reach and reputation for customer service, ZEONS will be the recognized sales contact and service support for Exmobaby. The company is known for specializing in consumer and industrial goods and has grown by 30% per year over the past 12 months. Being a multi-national conglomerate provides a sales and distribution infrastructure that is both broad and deep in most areas of the world.
According to David Bychkov, CEO of Exmovere Holdings Inc., "We are excited to begin a formal sales agency relationship with ZEONS. They are a growth company and an international conglomerate which fits perfectly with our current needs. We expect the synergies between the two companies to be not only mutually beneficial, but to help drive sales and tangible results. In addition, by tapping into the ZEONS sales and support model, Exmovere will be able to efficiently expand our potential quickly and efficiently throughout the world."
Exmovere Holdings focuses on creating new products based in emotion detection and biofeedback. The company uses existing technologies – including hardware and software – in combination with its proprietary and patented algorithms. This leading edge and powerful combination enables engineering and development of user friendly products which serve a biomedical purpose. As an example, the Exmobaby infant pajama is based on licensed and patented smart-garment technology from Sensatex and Georgia Tech. The pajama itself contains biosensors that send signals to a Zigbee-based, wireless transmitter. Vital signs and related biophysical signals about baby – when the Exmobaby pajama is being worn – that pass through the system are used to report, track and monitor how baby is doing.
Exmobaby is specifically designed by Exmovere to use the information from the biomedical system to provide alerts and information to parents and medical professionals – without direct human intervention. One of the concerns with phenomenon like Sudden Infant Death Syndrome (SIDS) and many other baby maladies is that relying on human intervention to monitor and interpret what's happening with baby often results in parent or medical care-giver awareness only when it's too late. The Exmobaby product offers an opportunity to get critical information in real time so that parents and medical professionals will know what's going on without having to guess or worry.
Around the world, there are significant resources and efforts dedicated to helping new mothers, the medical community, and others understand as much as possible about SIDS and other events tied to infant mortality. Exmovere Holdings created and designed Exmobaby specifically to help these people work with infants and use the biophysical information baby generates naturally in ways that can help.
One of the key reasons the company selected ZEONS Global for international distribution is tied to precisely because the company has access points around the globe and in countries where infant medical care is a constant concern. Dr. Jun Quion, Interim Chief Medical Officer and member of the Board of Directors at Exmovere Holdings Inc., recently stated: "The relationship with ZEONS Global will vastly improve Exmovere's ability to reach target communities and new parents around the world."
And, according to Asim Khan, the CEO of ZEONS Global, "We are very excited to have been selected by Exmovere as their distribution partner in developing a strong international presence. Many people in these emerging markets are open to using innovative technologies as early adopters which allows them to overcome the hurdles in providing needed services using mainstream systems. By introducing Exmobaby to countries where mortality rates are significantly higher, we look forward to making a positive contribution to the communities we do business in."
About Exmovere Holdings Inc.
Exmovere Holdings, Inc. (Frankfurt:X3M) is focused on government and consumer applications for healthcare, mobility, and security and the practical applications of the study of human emotion. The Chariot, Exmobaby pajamas, and the Telepath wristwatch are instrumental in the build out of this vision as a solid representation of Exmovere's push into enhancing human mobility, infant safety, and telemedicine. The company plans on continuing along a path of solid and emotional driven design with a product offering that changes the way people look at the world. The company believes these products will continue to be on the cutting edge and establish paradigm shifts in the markets we serve. Further inquiries into any of our exciting and innovative product offerings or our plans for go-to-market introductions during 2011 should be directed to the contact person listed below.
The Exmovere Holdings, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=7861
Certain of the above statements contained in this press release contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Actual results, events, and circumstances (including future performance, results, and trends) could differ materially from those set forth in such statements due to various factors, risks, and uncertainties, including, but not limited to, risks associated with the company's future growth and operating results, the uncertainty of market acceptance of the company's products, technological change, competitive factors, and general economic conditions. Except as otherwise required to be disclosed in periodic reports required to be filed by companies registered under the Exchange Act by rules of the Securities and Exchange Commission, the company has no duty and undertakes no obligation to update such statements.